# Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Catheters

> **NCT00322270** · PHASE3 · COMPLETED · sponsor: **ARCA Biopharma, Inc.**

## Conditions studied

- Thrombosis
- Venous Thrombosis
- Catheter Occlusion

## Interventions

- **DRUG:** Alfimeprase

## Key facts

- **NCT ID:** NCT00322270
- **Lead sponsor:** ARCA Biopharma, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2008-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00322270

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00322270, "Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Catheters". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00322270. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*